Suppr超能文献

载脂蛋白 E 基因的 DNA 甲基化在路易体痴呆中发生改变。

APOE DNA methylation is altered in Lewy body dementia.

机构信息

Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.

Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.

出版信息

Alzheimers Dement. 2018 Jul;14(7):889-894. doi: 10.1016/j.jalz.2018.02.005. Epub 2018 Mar 12.

Abstract

INTRODUCTION

Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person's risk of developing both Alzheimer's disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to investigate APOE methylation in LBD.

METHODS

Genomic DNA from postmortem brain tissues (frontal lobe and cerebellum) of neuropathological pure (np) controls and npAD, LBD + AD, and npLBD subjects were bisulfite pyrosequenced. DNA methylation levels of two APOE subregions were then compared for these groups.

RESULTS

APOE DNA methylation was significantly reduced in npLBD compared with np controls, and methylation levels were lowest in the LBD + AD group.

DISCUSSION

Given that npLBD and npAD postmortem brains shared a similar reduction in APOE methylation, it is possible that an aberrant epigenetic change in APOE is linked to risk for both diseases.

摘要

简介

载脂蛋白 E (APOE) 的 ε4 等位基因的遗传增加了一个人患阿尔茨海默病 (AD) 和路易体痴呆症 (LBD) 的风险,但这种风险背后的潜在机制尚不完全清楚。最近在 AD 尸检大脑中发现 APOE DNA 甲基化减少,促使本研究调查 LBD 中的 APOE 甲基化。

方法

对神经病理学纯 (np) 对照组和 npAD、LBD+AD 和 npLBD 受试者的死后脑组织(额叶和小脑)中的基因组 DNA 进行亚硫酸氢盐焦磷酸测序。然后比较这些组中两个 APOE 亚区的 DNA 甲基化水平。

结果

与 np 对照组相比,npLBD 中的 APOE DNA 甲基化显著降低,而在 LBD+AD 组中甲基化水平最低。

讨论

鉴于 npLBD 和 npAD 尸检大脑中 APOE 甲基化减少相似,APOE 中异常的表观遗传变化可能与两种疾病的风险相关。

相似文献

1
APOE DNA methylation is altered in Lewy body dementia.
Alzheimers Dement. 2018 Jul;14(7):889-894. doi: 10.1016/j.jalz.2018.02.005. Epub 2018 Mar 12.
2
The APOE Gene is Differentially Methylated in Alzheimer's Disease.
J Alzheimers Dis. 2015;48(3):745-55. doi: 10.3233/JAD-143060.
3
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
Am J Geriatr Psychiatry. 2006 Dec;14(12):1022-31. doi: 10.1097/01.JGP.0000225088.29353.08. Epub 2006 Sep 6.
4
Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
Dement Geriatr Cogn Disord. 2002;14(4):167-75. doi: 10.1159/000066022.
5
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Exp Neurol. 2000 Apr;162(2):247-56. doi: 10.1006/exnr.2000.7342.
6
Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
Brain Res. 2018 Nov 1;1698:179-186. doi: 10.1016/j.brainres.2018.08.006. Epub 2018 Aug 3.
8
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Alzheimers Dement. 2014 Sep;10(5):530-540.e1. doi: 10.1016/j.jalz.2013.03.010. Epub 2013 Aug 24.
9
Assessment of APOE in atypical parkinsonism syndromes.
Neurobiol Dis. 2019 Jul;127:142-146. doi: 10.1016/j.nbd.2019.02.016. Epub 2019 Feb 21.
10
ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology.
Neurology. 2018 Sep 18;91(12):e1182-e1195. doi: 10.1212/WNL.0000000000006212. Epub 2018 Aug 24.

引用本文的文献

1
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
2
The epigenetic modification of DNA methylation in neurological diseases.
Front Immunol. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962. eCollection 2024.
4
Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier.
MedComm (2020). 2024 Jul 13;5(7):e638. doi: 10.1002/mco2.638. eCollection 2024 Jul.
5
DNA methylation: The epigenetic mechanism of Alzheimer's disease.
Ibrain. 2023 Aug 10;9(4):463-472. doi: 10.1002/ibra.12121. eCollection 2023 Winter.
7
Genome-wide methylomic regulation of multiscale gene networks in Alzheimer's disease.
Alzheimers Dement. 2023 Aug;19(8):3472-3495. doi: 10.1002/alz.12969. Epub 2023 Feb 22.

本文引用的文献

1
DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies.
Psychiatry Clin Neurosci. 2017 Jan;71(1):28-35. doi: 10.1111/pcn.12462. Epub 2016 Nov 3.
2
Exome sequencing in dementia with Lewy bodies.
Transl Psychiatry. 2016 Feb 2;6(2):e728. doi: 10.1038/tp.2015.220.
3
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns.
Transl Psychiatry. 2016 Jan 19;6(1):e718. doi: 10.1038/tp.2015.214.
4
The APOE Gene is Differentially Methylated in Alzheimer's Disease.
J Alzheimers Dis. 2015;48(3):745-55. doi: 10.3233/JAD-143060.
5
Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies.
Int J Biochem Cell Biol. 2015 Oct;67:58-64. doi: 10.1016/j.biocel.2015.05.009. Epub 2015 May 21.
6
Clinical Features of Alzheimer Disease With and Without Lewy Bodies.
JAMA Neurol. 2015 Jul;72(7):789-96. doi: 10.1001/jamaneurol.2015.0606.
7
Epigenetic considerations of the APOE gene. [corrected].
Biomol Concepts. 2015 Mar;6(1):77-84. doi: 10.1515/bmc-2014-0039.
8
Molecular imaging biomarkers for dementia with Lewy bodies: an update.
Int Psychogeriatr. 2015 Apr;27(4):555-77. doi: 10.1017/S1041610214002555. Epub 2014 Dec 22.
9
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease.
Nat Neurosci. 2014 Sep;17(9):1164-70. doi: 10.1038/nn.3782. Epub 2014 Aug 17.
10
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci.
Nat Neurosci. 2014 Sep;17(9):1156-63. doi: 10.1038/nn.3786. Epub 2014 Aug 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验